Cardiff Oncology Stock Plunges After Sudden Leadership Change, Narrowed Trial Focus

Cardiff Oncology Inc. (NASDAQ:CRDF) on Tuesday closed around 32% lower after the management update and trial update.Mani Mohindru, a board member since 2021, was named interim CEO, effective immediately. Mark Erlander, CEO, and James Levine, CFO, have stepped down.To maintain financial continuity, Brigitte Lindsay was promoted to Chief Accounting Officer. She has been with the company for more than 14 years and most recently served as Senior Vice President of Finance. Cardiff Oncology has begun a search for ...